ObvioHealth, Dedalus group: decentralized trial partnership
Virtual research organization ObvioHealth is collaborating with life-sciences software specialist Dedalus Group. The partnership will merge ObvioHealth’s decentralized trial tools and Dedalus’s software products in an effort to make connections between research and EHR data.
Ivan Jarry, CEO of ObvioHealth, said, “The integration of clinical research with the data that sits within EHRs has the potential to be a game changer. Dedalus and ObvioHealth are enabling more precise identification of cohorts for trials while also facilitating longitudinal analyses that can identify new indications and/or long-term impacts of certain treatments.”